Swiss National Bank - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,816,768
-57.4%
179,200
+2.0%
0.01%
-54.5%
Q2 2023$16,006,270
+27.1%
175,700
-8.0%
0.01%
+22.2%
Q1 2023$12,598,360
+14.8%
191,000
-10.0%
0.01%
+12.5%
Q4 2022$10,972,862
-20.5%
212,200
+5.0%
0.01%
-20.0%
Q3 2022$13,803,000
+65.7%
202,100
+9.7%
0.01%
+66.7%
Q2 2022$8,330,000
-9.5%
184,200
+1.7%
0.01%
+20.0%
Q1 2022$9,202,000
+15.2%
181,100
+7.2%
0.01%0.0%
Q4 2021$7,986,000
+81.6%
168,900
+26.6%
0.01%
+66.7%
Q3 2021$4,397,000
-47.6%
133,400
+0.4%
0.00%
-40.0%
Q2 2021$8,399,000
+50.8%
132,900
+2.4%
0.01%
+25.0%
Q1 2021$5,570,000
-24.0%
129,800
+1.2%
0.00%
-20.0%
Q4 2020$7,333,000
+77.6%
128,200
-6.4%
0.01%
+66.7%
Q3 2020$4,130,000
-6.1%
136,900
+1.7%
0.00%
-25.0%
Q2 2020$4,396,000
+44.1%
134,600
+18.2%
0.00%
+33.3%
Q1 2020$3,051,000
+16.8%
113,900
+33.5%
0.00%0.0%
Q4 2019$2,612,000
+30.5%
85,300
+2.6%
0.00%
+50.0%
Q3 2019$2,002,000
-2.6%
83,100
+2.5%
0.00%0.0%
Q2 2019$2,055,000
+32.8%
81,100
+2.1%
0.00%0.0%
Q1 2019$1,548,000
+85.2%
79,400
+25.2%
0.00%
+100.0%
Q4 2018$836,000
-25.8%
63,4000.0%0.00%0.0%
Q3 2018$1,127,000
+74.7%
63,400
+116.4%
0.00%0.0%
Q2 2018$645,00029,3000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders